Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database
Αλεξάνδρα Παπαϊωάννου(Western University), Charlie H. Goldsmith(St. Joseph’s Healthcare Hamilton), Jacques P. Brown(Centre hospitalier de l'Université Laval), Nicole Ferko(Hamilton Health Sciences), David A. Hanley(The University of Sydney), Mark Puglia(McMaster University), George Ioannidis(McMaster University Medical Centre), Jonathan D. Adachi(St. Peter's Hospital), Alan Tenenhouse(St. Vincent's Birmingham), Pauline Boulos(McMaster University), Robert Josse(University of Toronto), Annie Petrie(McMaster University), Rolf J. Sebaldt(Murdoch Children's Research Institute), Timothy M. Murray(Beaumont Hospital), Wojciech P. Olszynski(University of Saskatchewan)
Cited by 92
Related Papers
Body mass index as a predictor of fracture risk: A meta-analysis
|Osteoporosis International|2005|1.6k
Predictive Value of BMD for Hip and Other Fractures
|Journal of Bone and Mineral Research|2005|1.5k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k